Nephrectomy is a surgical procedure for the removal of a kidney. The procedure is
preformed to treat various kidney problems such as kidney cancer, and kidney diseases
such as symptomatic hydronephrosis, chronic infection and polycystic kidney disease. It is
also done during kidney transplant. There are various types of nephrectomy procedures
such as laparoscopic surgery, robot-assisted laparoscopic surgery, open surgery, radical
nephrectomy and partial nephrectomy.
The Global Nephrectomy Market is expected to grow at a CAGR of 5.8% during the forecast
period 2017-2023.
The global market for nephrectomy is driven by increasing prevalence of kidney cancer and
chronic kidney diseases and increasing number of laparoscopic procedures. Additionally,
advancement in laparoscopic nephrectomy also fuels the market growth. Furthermore,
favorable reimbursement policies, increased application and significant investments in the
development of new technologies for the treatment of diseases will fuel the market growth
during the forecast period. Moreover, increasing geriatric population with chronic diseases
such as diabetes and obesity will fuel the market growth.
As per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
kidney disease is often referred to as a “silent disease” as there are no symptoms in its
early stages and can go undetected. Chronic kidney disease (CKD) is a global health burden
risk factor for cardiovascular disease (CVD). High blood pressure and diabetes are the main
causes of CKD. High economic cost to health systems and decreased productivity are major
drawbacks of kidney diseases. NIDDK also stated that the overall prevalence of Chronic
Kidney Disease (CKD) in the general population is approximately 14%. It also stated that in
2013, Medicare spending for patients with CKD aged 65 and older exceeded USD 50 billion
which accounted for 20% of all Medicare spending in this age group. More than 70% of
Medicare spending for CKD patients aged 65 and older was incurred by those who also had
diabetes, congestive heart failure, or both.
Key Players
Key players in the market are Karl Storz GmbH & Co.KG (Germany), Olympus Corporation
(Japan), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Stryker Corporation
(U.S.), Richard Wolf GMBH (Germany), Ethicon, Inc. (U.S.), Smith & Nephew PLC (U.K),
Cook Medical Incorporated (U.S.), and ConMed Corporation (U.S.), XCELLANCE Medical
Technologies (India), and others.
Get Sample Copy at https://www.marketresearchfuture.com/sample_request/5356 .
Segmentations
The Global Nephrectomy Market is segmented on the basis of procedure, products,
indication and end user.
On the basis of the procedure, it is segmented into laparoscopic surgery, robot-assisted
laparoscopic surgery, open surgery, radical nephrectomy and partial nephrectomy.
On the basis of the products, it is segmented into nephrectomy surgical kits, vascular
clamps, suturing needles and others.
On the basis of the indication, it is segmented into kidney cancer and kidney disease.
Kidney cancer is further segmented into renal cell cancer, Wilm’s tumour, transitional cell
cancer and others. Kidney disease is further segmented into symptomatic hydronephrosis,
chronic infection, polycystic kidney disease, hypertension or renal calculus and others.
Based on the end user, it is segmented into hospitals & clinics, nephrology center, research
institutes, and others.
Regional Analysis
The Americas nephrectomy market is expected to show extensive growth owing to
increasing of patient population with kidney cancer, and technological advancement in the
healthcare also accelerates the market growth. North America is the largest market whose
growth is driven by increasing healthcare spending, and increasing government support for
research & development will boost the market growth. Furthermore, extensive use of
laparoscopic instruments and concentration of key players influence in the market growth.